Fresenius SE & Co. KGaA
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
RSS
|
German
Who we are
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Corporate Governance
Business Development / M&A
Environment
History
Frequently Asked Questions
Investor Relations
Fresenius Share/ADR
Credit Relations
News
Publications
Presentations
Directors' Dealings
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Press
Press Releases
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Press Kit 100 Years
Health Care
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
All Segments
Calendar
Links
Contacts
Career
SEARCH
Fresenius Share/ADR
Credit Relations
News
Investor News
Ad hoc News
2013
2012
2011
2010
2009
2008
2007
2006
2005
Publications
Presentations
Directors' Dealings
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Share Price
AD Hoc News 2012
20.07.2012
Fresenius Kabi acquires Fenwal Holdings, Inc.
Text as PDF file
11.06.2012
Fresenius raises 2012 outlook – Fresenius Kabi exceeding expectations
Text as PDF file
11.05.2012
Fresenius successfully completes capital increase
Text as PDF file
10.05.2012
Fresenius resolves on capital increase of approx. €1 billion
Text as PDF file
26.04.2012
Fresenius announces plan to acquire all outstanding shares of RHÖN-KLINIKUM Aktiengesellschaft, raises 2012 outlook
Text as PDF file
24.02.2012
APP Pharmaceuticals receives FDA warning letter regarding Grand Island plant - no material financial impact expected
Text as PDF file
21.02.2012
Fresenius achieves record sales and earnings in 2011–
Text as PDF file
Home
>
Investor Relations
>
News
>
Ad hoc News
>
2012